연구동향 분석
박사

Application of D-allulose : mice to human efficacy regarding to body fat reduction : 알룰로스의 실제적용을 위한 동물 및 인체에서의 알룰로스의 항 비만 기능성 평가

한영지 2019년

논문상세정보
인용/피인용
' Application of D-allulose : mice to human efficacy regarding to body fat reduction : 알룰로스의 실제적용을 위한 동물 및 인체에서의 알룰로스의 항 비만 기능성 평가' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 음식과 음료
  • rare sugar
  • ; D-allulose
  • diet-induced obesity
  • gastrointestinal tolerance test
  • mRNA sequencing
  • monosaccharide
  • pyrosequencing
  • randomized controlled trial
  • sugar substitute
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,166 0

0.0%

' Application of D-allulose : mice to human efficacy regarding to body fat reduction : 알룰로스의 실제적용을 위한 동물 및 인체에서의 알룰로스의 항 비만 기능성 평가' 의 참고문헌

  • World Health Organization. (1990). Diet, nutrition and the prevention of chronic diseases: Report of a WHO study group [meeting held in geneva from 6-13 march 1989].
  • White, U. A., & Tchoukalova, Y. D. (2014). Sex dimorphism and depot differences in adipose tissue function. Biochimica Et Biophysica Acta (BBA)-Molecular Basis of Disease, 1842(3), 377-392.
  • Wang, J., Tang, H., Zhang, C., Zhao, Y., Derrien, M., Rocher, E., et al. (2015). Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. The ISME Journal, 9(1), 1.
  • Turnbaugh, P. J., Ridaura, V. K., Faith, J. J., Rey, F. E., Knight, R., & Gordon, J. I. (2009). The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Science Translational Medicine, 1(6), 6ra14.
  • Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 444(7122), 1027.
  • Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., et al. (2009). A core gut microbiome in obese and lean twins. Nature, 457(7228), 480.
  • Turnbaugh, P. J., B ckhed, F., Fulton, L., & Gordon, J. I. (2008). Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host & Microbe, 3(4), 213-223.
  • Turnbaugh, P. J., & Gordon, J. I. (2009). The core gut microbiome, energy balance and obesity. The Journal of Physiology, 587(17), 4153-4158.
  • Trayhurn, P., & Wood, I. S. (2004). Adipokines: Inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition, 92(3), 347-355.
  • Tokunaga, K., Matsuzawa, Y., Ishikawa, K., & Tarui, S. (1983). A novel technique for the determination of body fat by computed tomography. International Journal of Obesity, 7(5), 437-445.
  • Tataranni, P. A., & Ortega, E. (2005). A burning question: Does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? Diabetes, 54(4), 917-927.
  • Tang, W. W., Kitai, T., & Hazen, S. L. (2017). Gut microbiota in cardiovascular health and disease. Circulation Research, 120(7), 1183-1196.
  • Takeshita, K., Suga, A., Takada, G., & Izumori, K. (2000). Mass production of Dpsicose from D-fructose by a continuous bioreactor system using immobilized Dtagatose 3-epimerase. Journal of Bioscience and Bioengineering, 90(4), 453-455.
  • Svendsen, O. L., Haarbo, J., Hassager, C., & Christiansen, C. (1993). Accuracy of measurements of body composition by dual-energy x-ray absorptiometry in vivo. The American Journal of Clinical Nutrition, 57(5), 605-608.
  • Sun, S., Ji, Y., Kersten, S., & Qi, L. (2012). Mechanisms of inflammatory responses in obese adipose tissue. Annual Review of Nutrition, 32, 261-286.
  • Strissel, K. J., Stancheva, Z., Miyoshi, H., Perfield, J. W., DeFuria, J., Jick, Z., et al. (2007). Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes, 56(12), 2910-2918.
  • Storey, D., Lee, A., Bornet, F., & Brouns, F. (2007). Gastrointestinal tolerance of erythritol and xylitol ingested in a liquid. European Journal of Clinical Nutrition, 61(3), 349-354.
  • Spruss, A., & Bergheim, I. (2009). Dietary fructose and intestinal barrier: Potential risk factor in the pathogenesis of nonalcoholic fatty liver disease. The Journal of Nutritional Biochemistry, 20(9), 657-662.
  • Sohn, W., Jun, D. W., Lee, K. N., Lee, H. L., Lee, O. Y., Choi, H. S., et al. (2015). Lactobacillus paracasei induces M2-dominant kupffer cell polarization in a mouse model of nonalcoholic steatohepatitis. Digestive Diseases and Sciences, 60(11), 3340-3350.
  • Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., et al. (1995). Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. New England Journal of Medicine, 333(20), 1301-1308.
  • Schwiertz, A., Taras, D., Sch fer, K., Beijer, S., Bos, N. A., Donus, C., et al. (2010). Microbiota and SCFA in lean and overweight healthy subjects. Obesity, 18(1), 190-195.
  • Sagan, C. (2011). The demon-haunted world: Science as a candle in the dark Ballantine Books.
  • Ruskone-Fourmestraux, A., Attar, A., Chassard, D., Coffin, B., Bornet, F., & Bouhnik, Y. (2003). A digestive tolerance study of maltitol after occasional and regular consumption in healthy humans. European Journal of Clinical Nutrition, 57(1), 26-30.
  • Rogovik, A. L., Chanoine, J., & Goldman, R. D. (2010). Pharmacotherapy and weightloss supplements for treatment of paediatric obesity. Drugs, 70(3), 335-346.
  • Ritze, Y., B rdos, G., Claus, A., Ehrmann, V., Bergheim, I., Schwiertz, A., et al. (2014). Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice. PloS One, 9(1), e80169.
  • Ripoll, C., Flouri , B., Megnien, S., Hermand, O., & Janssens, M. (2010). Gastrointestinal tolerance to an inulin-rich soluble roasted chicory extract after consumption in healthy subjects. Nutrition, 26(7), 799-803.
  • Reagan-Shaw, S., Nihal, M., & Ahmad, N. (2008). Dose translation from animal to human studies revisited. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, 22(3), 659-661.
  • Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., et al. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature, 464(7285), 59.
  • Park, P., Kim, C., Cho, S., Rha, C., Seo, D., & Lee, S. (2010). Aqueous spray-dried green tea extract regulates body weight and epididymal fat accumulation in mice. Korean Journal of Food Science and Technology, 42(1), 103-108.
  • Pang, S. S., & Le, Y. Y. (2006). Role of resistin in inflammation and inflammationrelated diseases. Cellular & Molecular Immunology, 3(1), 29-34.
  • Ouchi, N., Kihara, S., Funahashi, T., Matsuzawa, Y., & Walsh, K. (2003). Obesity, adiponectin and vascular inflammatory disease. Current Opinion in Lipidology, 14(6), 561-566.
  • Ohashi, K., Parker, J. L., Ouchi, N., Higuchi, A., Vita, J. A., Gokce, N., et al. (2010). Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. Journal of Biological Chemistry, 285(9), 6153-6160.
  • Ochiai, M., Onishi, K., Yamada, T., Iida, T., & Matsuo, T. (2014). D-psicose increases energy expenditure and decreases body fat accumulation in rats fed a highsucrose diet. International Journal of Food Sciences and Nutrition, 65(2), 245- 250.
  • Nishida, C., Uauy, R., Kumanyika, S., & Shetty, P. (2004). The joint WHO/FAO expert consultation on diet, nutrition and the prevention of chronic diseases: Process, product and policy implications. Public Health Nutrition, 7(1A; SPI), 245-250.
  • Nagata, Y., Kanasaki, A., Tamaru, S., & Tanaka, K. (2015b). D-psicose, an epimer of d-fructose, favorably alters lipid metabolism in Sprague–Dawley rats. Journal of Agricultural and Food Chemistry, 63(12), 3168-3176.
  • Nagata, Y., Kanasaki, A., Tamaru, S., & Tanaka, K. (2015a). D-psicose, an epimer of d-fructose, favorably alters lipid metabolism in Sprague–Dawley rats. Journal of Agricultural and Food Chemistry, 63(12), 3168-3176.
  • Murao, K., Yu, X., Cao, W. M., Imachi, H., Chen, K., Muraoka, T., et al. (2007). Dpsicose inhibits the expression of MCP-1 induced by high-glucose stimulation in HUVECs. Life Sciences, 81(7), 592-599.
  • Muegge, B. D., Kuczynski, J., Knights, D., Clemente, J. C., Gonzalez, A., Fontana, L., et al. (2011). Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science (New York, N.Y.), 332(6032), 970-974.
  • McNemar, Q. (1947). Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika, 12(2), 153-157.
  • Matthews, D., Hosker, J., Rudenski, A., Naylor, B., Treacher, D., & Turner, R. (1985). Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412-419.
  • Matsuo, T., Baba, Y., Hashiguchi, M., Takeshita, K., Izumori, K., & Suzuki, H. (2001). Dietary d‐psicose, a C‐3 epimer of d‐fructose, suppresses the activity of hepatic lipogenic enzymes in rats. Asia Pacific Journal of Clinical Nutrition, 10(3), 233- 237.
  • Matarese, G., Moschos, S., & Mantzoros, C. S. (2005). Leptin in immunology. Journal of Immunology (Baltimore, Md.: 1950), 174(6), 3137-3142.
  • Martinez, I., Wallace, G., Zhang, C., Legge, R., Benson, A. K., Carr, T. P., et al. (2009). Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota. Applied and Environmental Microbiology, 75(12), 4175-4184.
  • MARKS, H. H. (1960). Influence of obesity on morbidity and mortality. Bulletin of the New York Academy of Medicine, 36, 296-312.
  • Ludwig, D. S., & Ebbeling, C. B. (2018). The carbohydrate-insulin model of obesity: Beyond “Calories in, calories out”. JAMA Internal Medicine, 178(8), 1098-1103.
  • Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006). Microbial ecology: Human gut microbes associated with obesity. Nature, 444(7122), 1022.
  • Ley, R. E., Backhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005). Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the United States of America, 102(31), 11070-11075.
  • Ley, R. E. (2010). Obesity and the human microbiome. Current Opinion in Gastroenterology, 26(1), 5-11.
  • Lennerz, B., & Lennerz, J. K. (2018). Food addiction, high-glycemic-index carbohydrates, and obesity. Clinical Chemistry, 64(1), 64-71.
  • Lee, J., Son, H., & Ryu, O. (2017). Management status of cardiovascular disease risk factors for dyslipidemia among korean adults. Yonsei Medical Journal, 58(2), 326-338.
  • Lee, H., Kwon, S., Yon, M., Kim, D., Lee, J., Nam, J., et al. (2014). Dietary total sugar intake of koreans: Based on the korea national health and nutrition examination survey (KNHANES), 2008-2011. Journal of Nutrition and Health, 47(4), 268- 276.
  • Lecomte, V., Kaakoush, N. O., Maloney, C. A., Raipuria, M., Huinao, K. D., Mitchell, H. M., et al. (2015). Changes in gut microbiota in rats fed a high fat diet correlate with obesity-associated metabolic parameters. PloS One, 10(5), e0126931.
  • Lambertz, J., Weiskirchen, S., Landert, S., & Weiskirchen, R. (2017). Fructose: A dietary sugar in crosstalk with microbiota contributing to the development and progression of non-alcoholic liver disease. Frontiers in Immunology, 8, 1159.
  • Kusminski, C. M., McTernan, P. G., & Kumar, S. (2005). Role of resistin in obesity, insulin resistance and type II diabetes. Clinical Science (London, England : 1979), 109(3), 243-256.
  • Kim, S., Kim, S. J., Kim, H., & Sung, M. (2017). D-psicose, a sugar substitute, suppresses body fat deposition by altering networks of inflammatory response and lipid metabolism in C57BL/6J-ob/ob mice. Journal of Functional Foods, 28, 265-274.
  • Kim, H. J., Hyun, E. K., Kim, Y. S., Lee, Y. J., & Oh, D. K. (2006). Characterization of an agrobacterium tumefaciens D-psicose 3-epimerase that converts D-fructose to D-psicose. Applied and Environmental Microbiology, 72(2), 981-985.
  • Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergstr m, G., Behre, C. J., Fagerberg, B., et al. (2013). Gut metagenome in european women with normal, impaired and diabetic glucose control. Nature, 498(7452), 99.
  • Jung, U., & Choi, M. (2014). Obesity and its metabolic complications: The role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. International Journal of Molecular Sciences, 15(4), 6184-6223.
  • Jones, D. Y., Judd, J. T., Taylor, P. R., Campbell, W. S., & Nair, P. P. (1988). Menstrual cycle effect on plasma lipids. Metabolism, 37(1), 1-2.
  • Hulcher, F. H., & Oleson, W. H. (1973). Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A. Journal of Lipid Research, 14(6), 625-631.
  • Hu, F. B. (2013). Resolved: There is sufficient scientific evidence that decreasing sugar‐sweetened beverage consumption will reduce the prevalence of obesity and obesity‐related diseases. Obesity Reviews, 14(8), 606-619.
  • Hossain, M. A., Kitagaki, S., Nakano, D., Nishiyama, A., Funamoto, Y., Matsunaga, T., et al. (2011). Rare sugar D-psicose improves insulin sensitivity and glucose tolerance in type 2 diabetes otsuka long-evans tokushima fatty (OLETF) rats. Biochemical and Biophysical Research Communications, 405(1), 7-12.
  • Hossain, A., Yamaguchi, F., Hirose, K., Matsunaga, T., Sui, L., Hirata, Y., et al. (2015). Rare sugar D-psicose prevents progression and development of diabetes in T2DM model otsuka long-evans tokushima fatty rats. Drug Design, Development and Therapy, 9, 525-535.
  • Hill, J. O., Wyatt, H. R., & Peters, J. C. (2012). Energy balance and obesity. Circulation, 126(1), 126-132.
  • Hayashi, N., Yamada, T., Takamine, S., Iida, T., Okuma, K., & Tokuda, M. (2014). Weight reducing effect and safety evaluation of rare sugar syrup by a randomized double-blind, parallel-group study in human. Journal of Functional Foods, 11, 152-159.
  • Han, Y., Kwon, E., Yu, M. K., Lee, S. J., Kim, H., Kim, S., et al. (2018). A preliminary study for evaluating the dose-dependent effect of D-allulose for fat mass reduction in adult humans: A randomized, double-blind, placebo-controlled trial. Nutrients, 10(2), 160.
  • Han, Y., Han, H. J., Kim, A., Choi, J., Cho, S., Park, Y. B., et al. (2016). d‐Allulose supplementation normalized the body weight and fat‐pad mass in diet‐induced obese mice via the regulation of lipid metabolism under isocaloric fed condition. Molecular Nutrition & Food Research, 60(7), 1695-1706.
  • Granstr m, T. B., Takata, G., Tokuda, M., & Izumori, K. (2004). Izumoring: A novel and complete strategy for bioproduction of rare sugars. Journal of Bioscience and Bioengineering, 97(2), 89-94.
  • Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry, 18(6), 499-502.
  • Fox, C. S., Massaro, J. M., Hoffmann, U., Pou, K. M., Maurovich-Horvat, P., Liu, C. Y., et al. (2007). Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the framingham heart study. Circulation, 116(1), 39-48.
  • Faul, F., Erdfelder, E., Buchner, A., & Lang, A. (2009). Statistical power analyses using G* power 3.1: Tests for correlation and regression analyses. Behavior Research Methods, 41(4), 1149-1160.
  • FOLCH, J., LEES, M., & SLOANE STANLEY, G. H. (1957). A simple method for the isolation and purification of total lipides from animal tissues. The Journal of Biological Chemistry, 226(1), 497-509.
  • Dong, C., Wang, X., Xu, H., Zhan, X., Ren, H., Liu, Z., et al. (2017). Identification of a cytokine-cytokine receptor interaction gene signature for predicting clinical outcomes in patients with colorectal cancer. Int J Clin Exp Med, 10(6), 9009- 9018.
  • Dietschy, J. M., & Wilson, J. D. (1970). Regulation of cholesterol metabolism. New England Journal of Medicine, 282(22), 1241-1249.
  • Dewulf, E. M., Cani, P. D., Neyrinck, A. M., Possemiers, S., Van Holle, A., Muccioli, G. G., et al. (2011). Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. The Journal of Nutritional Biochemistry, 22(8), 712-722.
  • Crescenzo, R., Mazzoli, A., Di Luccia, B., Bianco, F., Cancelliere, R., Cigliano, L., et al. (2017). Dietary fructose causes defective insulin signalling and ceramide accumulation in the liver that can be reversed by gut microbiota modulation. Food & Nutrition Research, 61(1), 1331657.
  • Cordain, L., Eaton, S. B., Sebastian, A., Mann, N., Lindeberg, S., Watkins, B. A., et al. (2005). Origins and evolution of the western diet: Health implications for the 21st century. The American Journal of Clinical Nutrition, 81(2), 341-354.
  • Carlson, S., & GRAS, Generally Recognized As Safe. (2011). Notifier's name and address: CJ cheiljedang, inc.
  • Browning, J. D., Szczepaniak, L. S., Dobbins, R., Horton, J. D., Cohen, J. C., Grundy, S. M., et al. (2004). Prevalence of hepatic steatosis in an urban population in the united states: Impact of ethnicity. Hepatology, 40(6), 1387-1395.
  • Berg, A. H., Combs, T. P., & Scherer, P. E. (2002). ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism. Trends in Endocrinology & Metabolism, 13(2), 84-89.
  • Baothman, O. A., Zamzami, M. A., Taher, I., Abubaker, J., & Abu-Farha, M. (2016). The role of gut microbiota in the development of obesity and diabetes. Lipids in Health and Disease, 15(1), 108.
  • Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., et al. (1999). Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications, 257(1), 79-83.
  • Ahima, R. S., & Flier, J. S. (2000). Adipose tissue as an endocrine organ. Trends in Endocrinology & Metabolism, 11(8), 327-332.